Ireland-based Creganna-Tactx Medical continued to vie for its seat among top minimally invasive device makers with the acquisition of Irish compatriot ABT Medical for an undisclosed amount.
ABT’s portfolio of medical balloons includes a the longest commercially available balloon components in the industry, up to and beyond 300 mm in length, according to a press release.
"Pursuant to our growth strategy, the acquisition of ABT represents a strategic opportunity to further develop our customer partnerships and strengthen our technology portfolio particularly for the rapidly expanding peripheral vascular device market," CEO Helen Ryan told MassDevice.com today.
Creganna-Tactx, formed in January 2010 when Creganna and Tactx Medical merged and "ranked among the top 10 global companies in the medical device outsourcing industry," has a global footprint spanning the U.S., Europe and Asia, according to the company.
Last year the company also opened an office in a business incubator on Cleveland Clinic’s campus.
ABT Medical’s technology joins Creganna-Tactx’s existing suite of balloon design and manufacturing, particularly in peripheral vascular devices where "the most sophisticated balloon specifications are required," the company announced.
ABT Medical’s technologies, which include medical balloons, are immediately available to Creganna-Tactx customers worldwide, according to a press release.